Addictions, Drug & Alcohol Institute


August 4, 2023

ADAI In the News: A Round-Up of Stories on Xylazine, Fentanyl, Meth Overdose, “Health Hubs,” and More!

Hand holding cell phone with website loaded on the screen reading NEWS at the top

ADAI faculty and staff have been featured in a lot of news articles and other media lately. Here’s a round-up of some of the pieces and podcasts. (Want to be the first to know when ADAI folks are in the media? Follow us on X/Twitter!) Xylazine or “tranq” in WA: Rising drug threat or an…

July 6, 2023

New Podcast Episode Featuring Dr. Mandy Owens: Substance Use and The Reentry Process

Dr. Mandy Owens podcast episode

This week, ADAI Assistant Professor Mandy Owens, PhD was interviewed on the More Life: The Reentry Podcast by host VanKe’via Garner, MS to talk about the intersection of substance use disorders and the criminal legal system. For people with a substance use disorder (SUD), reentry after jail or prison can be a particularly dangerous time….

March 29, 2023

NEW: U.S. FDA Approves Narcan (4mg Naloxone Nasal Spray) for Over-The-Counter Purchase/Use

Narcan approved for OTC purchase/use with photo of naloxone nasal spray box and device

From the US FDA press release: Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment…

February 15, 2023

ADAI in the News: Dr. Caleb Banta-Green on Over-the-Counter Naloxone and Low-Barrier Treatment

Hand holding cell phone with website loaded on the screen reading NEWS at the top

ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW recently talked with Scripps National News about making the opioid overdose antidote naloxone available over-the-counter (OTC). The FDA is meeting today (Feb. 15, 2023) to review the application for an OTC version of naloxone nasal spray. Though the goal of such a move would be to expand…

December 21, 2022

Taking Stock of WA State’s Decade of Legal Cannabis (KUOW, featuring ADAI’s Beatriz Carlini)

Hand holding cell phone with website loaded on the screen reading NEWS at the top

In this piece, KUOW’s Amy Radil provides information about the path legal cannabis has taken in Washington over the last 10 years and where it appears to be headed in the future. ADAI Director of the Cannabis Education & Research Program, Dr. Beatriz Carlini, is featured in the article, taking about risks associated with use…

December 1, 2022

Substance Use is a Health Issue, Not a Legal One – Op-Ed in the Seattle Times by Dr. Caleb Banta-Green

Seattle Times Logo

See also: December 2, 2022 KUOW interview with Dr. Banta-Green about the ongoing rise in fentanyl-related deaths and need for treatment options. ADAI Acting Professor Caleb Banta-Green, PhD authored an opinion piece published in the Seattle Times on November 30, 2022 urging the Washington State Legislature and governor to act on recommendations made by the…

November 10, 2022

Looking for ADAI Events?

Photo of person holding phone in one hand and writing on calendar with other

Looking for upcoming events hosted by the UW Addictions, Drug & Alcohol Institute? You can find our events a few different ways: Subscribe to the ADAI News & Events blog (this!) and get notices about events hosted by ADAI and its various centers and teams (CEDEER, CAAHS and the Northwest ATTC, CERP, CTN, and more!),…

November 4, 2022

How Can We Solve King County’s Fentanyl Problem? Seattle Met Article Feat. Caleb Banta-Green

Seattle Met: How Can We Solve King County's Fentanyl Problem?

Seattle Met magazine has two new stories about fentanyl in King County, both by Angela Cabotaje. The first, “How Can We Solve King County’s Fentanyl Problem?,” features ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW, describing the impact pharmaceutical companies had on the opioid overdose crisis, and the innovative program Bupe Pathways, which is helping…

November 1, 2022

ADAI’s Bia Carlini, PhD Interviewed on Q13 About High-THC Cannabis Products

Bia Carlini screenshot of Q13 interview

Acting Associate Professor Beatriz Carlini, PhD, director of ADAI’s Cannabis Education & Research Program (CERP), was recently interviewed for Q13 FOX about the health risks of high-THC cannabis products. Dr. Carlini talks in the video about how cannabis legalization brought new jobs and less criminalization of individuals, both good things, but that the market has…

October 13, 2022

ADAI’s Dr. Susan Stoner Appointed as Holder Ann Streissguth Endowed Professorship in FASD

Photo of Dr. Stoner and text Congratulations to Dr Susan Stoner, holder of the Ann Streissguth Endowed Professorship in FASD. ADAI and UW Psychiatry logos

In 1973, UW pediatricians Kenneth L. Jones, David W. Smith, and Christy Ulleland, along with psychologist Ann Streissguth, published a landmark study of 8 children born with serious disabilities and a specific pattern of birth defects that could only have been caused during gestational development – all 8 had alcoholic mothers. Jones and Smith named…

Next page